- Home
- PROK vs FMN Comparison
PROK vs FMN Comparison
Compare PROK & FMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- FMN
- Stock Information
- Founded
- PROK 2015
- FMN 2002
- Country
- PROK United States
- FMN United States
- Employees
- PROK N/A
- FMN N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- FMN Investment Managers
- Sector
- PROK Health Care
- FMN Finance
- Exchange
- PROK Nasdaq
- FMN Nasdaq
- Market Cap
- PROK 94.9M
- FMN 86.2M
- IPO Year
- PROK N/A
- FMN N/A
- Fundamental
- Price
- PROK $0.81
- FMN $10.78
- Analyst Decision
- PROK Buy
- FMN
- Analyst Count
- PROK 4
- FMN 0
- Target Price
- PROK $5.00
- FMN N/A
- AVG Volume (30 Days)
- PROK 796.9K
- FMN 22.8K
- Earning Date
- PROK 05-12-2025
- FMN 01-01-0001
- Dividend Yield
- PROK N/A
- FMN 3.86%
- EPS Growth
- PROK N/A
- FMN N/A
- EPS
- PROK N/A
- FMN N/A
- Revenue
- PROK $306,000.00
- FMN N/A
- Revenue This Year
- PROK N/A
- FMN N/A
- Revenue Next Year
- PROK N/A
- FMN N/A
- P/E Ratio
- PROK N/A
- FMN N/A
- Revenue Growth
- PROK N/A
- FMN N/A
- 52 Week Low
- PROK $0.46
- FMN $9.09
- 52 Week High
- PROK $4.44
- FMN $11.31
- Technical
- Relative Strength Index (RSI)
- PROK 49.17
- FMN 58.46
- Support Level
- PROK $0.94
- FMN $10.65
- Resistance Level
- PROK $0.87
- FMN $10.78
- Average True Range (ATR)
- PROK 0.11
- FMN 0.07
- MACD
- PROK 0.01
- FMN 0.02
- Stochastic Oscillator
- PROK 39.10
- FMN 92.20
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About FMN Federated Hermes Premier Municipal Income Fund
Federated Hermes Premier Municipal Income Fund is a United States-based diversified, closed-end management investment company. The investment objective of the fund is to provide current income exempt from federal income tax, including the federal alternative minimum tax by investing in long-term, tax exempt municipal bonds diversified among states, sectors and issuers. Its portfolio of investments comprises different sectors such as hospitals, toll road, senior care, airport, tobacco, and other sectors.